Aldevron News: New Hires & Promotions

Jennifer Meade Named President

FARGO, N.D. (September 11, 2023) – Jennifer Meade has been named President of Aldevron, effective September 11th 2023, as part of a planned leadership transition. She replaces Kevin Ballinger, who has departed Aldevron after leading the organization for three years.

Read More

Aldevron Names Matt Johnson Vice President of Information Technologies

Aldevron, a global leader in the manufacture of plasmid DNA, mRNA and proteins, announced the appointment of Matt Johnson as Vice President of Information Technologies (IT). In this newly-created executive role, Johnson will lead the IT team to ensure successful implementation and operation of key technology strategies.

Read More

Aldevron Names Shawn McCormick Chief Financial Officer

Aldevron, a global leader in the manufacture of plasmid DNA, mRNA and proteinstoday announced Shawn McCormick as its Chief Financial Officer. He will begin this new role immediately and will be a member of Aldevron’s executive team reporting to CEO Kevin Ballinger. 

Read More

Aldevron Promotes Venkata Indurthi to Vice President of Research and Development

Aldevron, a global leader in the manufacture of plasmid DNA, mRNA and proteins, has promoted Venkata Indurthi to Vice President of Research and Development (R&D).  He will begin this new role immediately and continue reporting to John Ballantyne, Co-founder and Chief Scientific Officer while having direct access to Aldevron’s senior executive team. 

Read More

In the news: Bloomberg Law - Aldevron Taps Legal Chief, Looks for Possible Covid Vaccine Role

Aldevron LLC, a company angling for a role in the production of Covid-19 vaccines, hired Rachel Lei as its first general counsel and corporate secretary.

Lei became Aldevron’s first general counsel in June. She joins new chief executive officer Kevin Ballinger, hired the following month, among other recent additions to the North Dakota-based company’s leadership team.

Read More

Rachel Lei Appointed as Aldevron General Counsel

Rachel Lei has joined Aldevron as its new General Counsel and Corporate Secretary. Lei will advise the Board of Directors and CEO on issues of overarching importance to Aldevron and will assist in setting and implementing Aldevron’s overall strategic direction , building and overseeing Aldevron’s legal department to ensure that its legal function operates as a true business partner.

Read More

Kevin Ballinger to Assume CEO Role at Aldevron; Michael Chambers to become Executive Chairman

Attracting one of med-tech’s most accomplished executives, Aldevron has named Kevin Ballinger as Chief Executive Officer, effective July 13, 2020. Aldevron’s co-founder, Michael Chambers, has been named Executive Chairman of the board. Chambers initiated the transition to allow him to focus on innovation, corporate strategy and working with clients and industry thought leaders to develop new technologies that enable genetic medicine. Ballinger will assume day-to-day operational leadership of Aldevron, facilitating the company’s rapid growth.

Read More